aspirin has been researched along with Lupus Erythematosus, Systemic in 199 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Excerpt | Relevance | Reference |
---|---|---|
"The pharmacologic effect of aspirin is suboptimal in 15% of patients with SLE but in none of the control subjects, and the suboptimal response was associated with metabolic syndrome, obesity, and higher CRP concentrations." | 9.19 | Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. ( Avalos, I; Chung, CP; Kawai, VK; Milne, GL; Oates, JA; Oeser, A; Solus, JF; Stein, CM, 2014) |
"The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS)." | 8.93 | The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. ( Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A, 2016) |
"We performed a meta-analysis to determine whether aspirin has a significant protective effect on risk of first thrombosis among patients with antiphospholipid antibodies (aPL+)." | 8.90 | Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. ( Amoura, Z; Arnaud, L; Balasch, J; Cervera, R; Erkan, D; Forastiero, R; Lambert, M; Martinez-Zamora, MA; Mathian, A; Pengo, V; Ruffatti, A; Tektonidou, M; Wahl, D; Zuily, S, 2014) |
"Hydroxychloroquine combined with low-dose aspirin can effectively improve the pregnancy outcomes of pregnant women with SLE by affecting the levels of T helper (Th) 2 and Th1 cytokines." | 8.31 | Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus. ( Li, Y; Li, YW; Zhang, HX; Zhang, N, 2023) |
"Women with lupus have an increased risk of preeclampsia and preterm birth, and aspirin 81 mg/day is recommended as a preventative measure for preeclampsia." | 7.91 | Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. ( Clowse, MEB; Eudy, AM; Myers, RA; Voora, D, 2019) |
"Aspirin resistance may be associated with increased risk of adverse pregnancy outcomes including preeclampsia, premature delivery and delivery of SGA newborns." | 7.77 | Aspirin resistance may be associated with adverse pregnancy outcomes. ( Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A, 2011) |
"A sudden hearing loss in a woman on aspirin has uncovered a frequently neglected toxicological parameter." | 7.75 | Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter. ( Koren, G, 2009) |
"We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 7.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
"After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 5.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
"In whole blood from 30 patients with systemic lupus erythematosus (SLE), 10 normal subjects, and 40 patients with active seropositive rheumatoid arthritis (RA), there were negative correlations between the hematocrit level and the ASA half-life in vitro: r = -0." | 5.27 | Patterns of in vitro aspirin hydrolysis rates in rheumatoid arthritis and systemic lupus erythematosus. ( Costello, PB; Green, FA, 1986) |
"The pharmacologic effect of aspirin is suboptimal in 15% of patients with SLE but in none of the control subjects, and the suboptimal response was associated with metabolic syndrome, obesity, and higher CRP concentrations." | 5.19 | Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. ( Avalos, I; Chung, CP; Kawai, VK; Milne, GL; Oates, JA; Oeser, A; Solus, JF; Stein, CM, 2014) |
"The objectives of this study are to examine the efficacy and safety of low-dose aspirin (LDA) vs LDA plus low-intensity warfarin (LDA + W) in the primary thrombosis prevention of aPL-positive patients with SLE and/or obstetric morbidity and the role of clinical and serological markers in the development of thrombosis." | 5.19 | Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). ( Aguirre, A; Akil, M; Amigo, MC; Bertolaccini, ML; Cuadrado, MJ; Egurbide, MV; Espinosa, G; Galindo, M; Gil, A; Gordon, C; Houssiau, F; Khamashta, MA; Martin, H; McHugh, N; Mico, L; Murru, V; Rahman, A; Ruiz-Irastorza, G; Seed, PT; Tektonidou, MG, 2014) |
"The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS)." | 4.93 | The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. ( Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A, 2016) |
"We performed a meta-analysis to determine whether aspirin has a significant protective effect on risk of first thrombosis among patients with antiphospholipid antibodies (aPL+)." | 4.90 | Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. ( Amoura, Z; Arnaud, L; Balasch, J; Cervera, R; Erkan, D; Forastiero, R; Lambert, M; Martinez-Zamora, MA; Mathian, A; Pengo, V; Ruffatti, A; Tektonidou, M; Wahl, D; Zuily, S, 2014) |
" Clinical trials have demonstrated that patients with antiphospholipid antibodies and venous thromboembolism should be treated with vitamin K antagonists (warfarin); that ischemic stroke may be treated with aspirin or warfarin; and that women with recurrent pregnancy loss should receive prophylactic-dose heparin and aspirin." | 4.85 | Antiphospholipid antibody syndrome. ( Lim, W, 2009) |
" Among SLE group, lower birth weight and smaller gestational age were observed in SLE mothers with disease active during pregnancy, kidney involved, blood system involved and not taking Aspirin during pregnancy." | 4.31 | Association of preterm outcome with maternal systemic lupus erythematosus: a retrospective cohort study. ( Bei, F; Bu, J; Chen, X; Di, W; Hu, Y; Jiang, M; Sun, J; Wu, J; Ye, L, 2023) |
"Hydroxychloroquine combined with low-dose aspirin can effectively improve the pregnancy outcomes of pregnant women with SLE by affecting the levels of T helper (Th) 2 and Th1 cytokines." | 4.31 | Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus. ( Li, Y; Li, YW; Zhang, HX; Zhang, N, 2023) |
"(1) To assess the clinical utility of the adjusted global antiphospholipid syndrome score (aGAPSS) to predict new obstetric events during follow-up in primary obstetric antiphospholipid syndrome (POAPS) patients under standard-of-care treatment (SC) based on the use of low-dose aspirin (LDA) + heparin and (2) to study the risk of a first thrombotic event and to evaluate whether stratification according to this score could help to identify POAPS patients who would benefit from long-term thromboprophylaxis." | 4.12 | Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome. ( Alijotas-Reig, J; Aranda, F; Belizna, C; de Larrañaga, G; Esteve-Valverde, E; Fernández-Romero, DS; Latino, JO; Peréz, SM; Udry, S; Wingeyer, SP, 2022) |
"Women with lupus have an increased risk of preeclampsia and preterm birth, and aspirin 81 mg/day is recommended as a preventative measure for preeclampsia." | 3.91 | Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. ( Clowse, MEB; Eudy, AM; Myers, RA; Voora, D, 2019) |
"Aspirin resistance may be associated with increased risk of adverse pregnancy outcomes including preeclampsia, premature delivery and delivery of SGA newborns." | 3.77 | Aspirin resistance may be associated with adverse pregnancy outcomes. ( Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A, 2011) |
" Serous retinal detachments were confirmed using fluorescein and indocyanine green angiography." | 3.76 | OCT follow-up of systemic lupus erythematosus choroidopathy. ( Bouillet, L; Chiquet, C; Kouprianoff, S; Romanet, JP, 2010) |
"A sudden hearing loss in a woman on aspirin has uncovered a frequently neglected toxicological parameter." | 3.75 | Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter. ( Koren, G, 2009) |
"We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day." | 3.74 | Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008) |
"Authors describe a successful pregnancy outcome after prednisone and aspirin therapy in 19-year-old woman with systemic lupus erythematosus with the history of recurrent urinary tract infections, pericarditis and encephalitis." | 3.71 | [Course of pregnancy in a patient with systemic lupus erythematosus--case report]. ( Goluda, M; Jerzak, MM; Podwysocka, M; Prusek, W, 2002) |
"This prospective study is an attempt to address the issues of whether or not antiphospholipid antibodies (aPL) constitute a significant risk factor for pregnancy in individuals with systemic lupus erythematosus (SLE) and whether or not combination therapy of high-dose prednisolone (PSL) and low-dose acetylsalicylic acid (ASA) offers efficient control." | 3.69 | A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus. ( Aoki, K; Hayashi, Y; Ogasawara, M, 1995) |
" Immunoadsorbent plasmapheresis with a dextran sulphate column was used to remove lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA during her fourth pregnancy in combination with low doses of aspirin and prednisolone." | 3.68 | Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. ( Hashimoto, H; Hirose, S; Kobayashi, S; Mokuno, C; Tamura, N; Tsuda, H, 1992) |
"A patient with systemic lupus erythematosus and elevated cardiolipin antibody levels was given low-dose aspirin therapy prior to and throughout her third pregnancy to minimize the risk of miscarriage." | 3.68 | Anticardiolipin syndrome, aspirin therapy and fetal malformation. ( Chakravarty, K; Merry, P, 1993) |
"Since systemic lupus erythematosus (SLE) is associated with platelet activation and increased cardiovascular mortality, we compared thromboxane and prostacyclin biosynthesis in patients with SLE and control subjects, and measured inhibition of thromboxane excretion in aspirin-treated subjects." | 2.73 | Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. ( Avalos, I; Borntrager, H; Chung, CP; Milne, GL; Morrow, JD; Oeser, A; Raggi, P; Solus, J; Stein, CM, 2007) |
"Pregnancy was successfully carried out in 12/12 (100%) SLE-RSA patients with a mean Apgar score of 8." | 2.73 | Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. ( Cipriani, P; De Carolis, C; Fontana, L; Giacomelli, R; Greco, E; Kröegler, B; Perricone, C; Perricone, R, 2008) |
"We studied 14 pregnant women with systemic lupus erythematosus (SLE), of whom six had detectable antiphospholipid antibodies." | 2.67 | Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin. ( Julkunen, H; Kaaja, R; Viinikka, L; Ylikorkala, O, 1993) |
"Aspirin has proved its efficacy in primary and secondary pre-eclampsia prevention, especially when it is given at 150mg per day bedtime before 15 weeks of gestation to high-risk women." | 2.58 | [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?] ( de Moreuil, C; Fauchais, AL; Lacut, K; Le Moigne, E; Merviel, P; Pan-Petesch, B; Pasquier, E; Tremouilhac, C, 2018) |
"Background Systemic lupus erythematosus is associated with an increased risk of cardiovascular disease." | 2.55 | Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review. ( Afeltra, A; Fasano, S; Margiotta, DP; Navarini, L; Pantano, I; Pierro, L; Riccardi, A; Valentini, G, 2017) |
"Miscarriage, premature delivery, and preeclampsia, as well as heart problems in the baby are the major complications that can occur." | 2.53 | Pregnancy in women with systemic lupus erythematosus (SLE). ( Moroni, G; Ponticelli, C, 2016) |
"The management of lupus nephritis in pregnancy presents a diagnostic and therapeutic challenge for providers." | 2.52 | Pregnancy and Lupus Nephritis. ( Garovic, VD; Kattah, AG, 2015) |
"a previous history of miscarriage, foetal loss, placental insufficiency or thrombosis." | 2.47 | Lupus and pregnancy: integrating clues from the bench and bedside. ( Khamashta, MA; Ruiz-Irastorza, G, 2011) |
"Women with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are subject to several complications during pregnancy, including reactivation of SLE, thrombosis, miscarriage, neonatal lupus, pregnancy-induced hypertension, pulmonary hypertension and drug toxicity." | 2.43 | [Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy]. ( Khamashta, MA; Ruiz-Irastorza, G, 2006) |
"Since 1987 the antiphospholipid syndrome has been recognized as a major cause of acquired thrombophilia, whether it is associated with systemic lupus erythematosus or occurs as a free-standing syndrome (primary form)." | 2.41 | [Antiphospholipid syndrome]. ( Arvieux, J; Hachulla, E, 2002) |
"Insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE) are two common autoimmune disorders that affect women of childbearing age." | 2.39 | Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes. ( Ferris, AM; Reece, EA, 1994) |
" Clinicians who decide to manage complicated or potentially complicated patients with chronic administration of aspirin must continue to study these mothers, fetuses, and neonates intensively and to document their results." | 2.38 | Low-dose aspirin to improve perinatal outcome. ( Barton, JR; Sibai, BM, 1991) |
"Aspirin may cause a transient shedding of renal tubular cells, alterations in urate excretion, inhibition of spironolactone action, and, in certain clinical settings, a reversible decline in renal function manifested as a fall in glomerular filtration that may be accompanied by mild water, sodium, and potassium retention." | 2.36 | Acute effects of aspirin and acetaminophen on renal function. ( Kimberly, RP; Plotz, PH, 1981) |
"Common complications of systemic lupus erythematosus include nephritis, hematologic complications such as thrombocytopenia, and a variety of neurologic abnormalities." | 1.91 | Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. ( Craigo, S; Kuller, JA; Norton, ME; Osmundson, SS; Porter, F; Silver, R, 2023) |
" In age-adjusted analyses, aspirin plus LMWH regardless of dosage was associated with significantly higher odds of live birth compared with no antithrombotic use (OR = 7." | 1.91 | Management and outcomes of women with antiphospholipid syndrome during pregnancy. ( Adurty, S; D'Angelo, D; DeSancho, MT; Tao, JJ, 2023) |
"Atherosclerosis develops early in systemic lupus erythematosus (SLE) patients and is an important cause of mortality." | 1.40 | Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus. ( Bae, CB; Jung, JY; Kim, HA; Koh, BR; Suh, CH, 2014) |
"Previous thrombosis, diagnosis of systemic lupus erythematosus (SLE) and triple antiphospholipid (aPL) antibody positivity have recently been found to be independent factors associated to pregnancy failure during conventional therapy in women with antiphospholipid syndrome (APS)." | 1.40 | Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. ( Alijotas-Reig, J; Andreoli, L; Bertero, MT; Bremme, K; Brucato, A; Canti, V; Caramaschi, P; De Carolis, S; Del Ross, T; Di Poi, E; Galeazzi, M; Gerosa, M; Maina, A; Mekinian, A; Meroni, PL; Mosca, M; Ramoni, V; Ruffatti, A; Salvan, E; Tincani, A; Trespidi, L, 2014) |
"Aspirin is an effective treatment option for these patients." | 1.39 | Aspirin resistance in systemic lupus erythematosus. A pilot study. ( Akdogan, A; Akman, U; Bilgen, SA; Buyukasik, Y; Dogan, I; Ertenli, I; Karadag, O; Kilic, L; Kiraz, S, 2013) |
"Systemic lupus erythematosus is a chronic autoimmune disorder which affects women with child bearing potential." | 1.38 | [Successful completed pregnancies in patients with systemic lupus erythematosus]. ( Kiss, E; Szegedi, G; Tarr, T; Zeher, M, 2012) |
"Systemic lupus erythematosus is a chronic inflammatory disorder that predisposes to acute coronary thrombosis." | 1.37 | Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. ( Matthai, WH; Patel, PJ; Untereker, WJ, 2011) |
"These findings were compatible with systemic lupus erythematosus (SLE)." | 1.36 | [Sporadic hemiplegic migraine-like headache in a patient with systemic lupus erythematosus]. ( Doi, H; Isobe, N; Kira, J; Ohyagi, Y; Tateishi, T; Yamasaki, R, 2010) |
"This was a rare case of severe influenza-associated hemophagocytic syndrome and steroid-resistant pericardial effusion in an SLE patient." | 1.36 | Influenza virus B-associated hemophagocytic syndrome and recurrent pericarditis in a patient with systemic lupus erythematosus. ( Ando, H; Horai, Y; Minami, R; Miyamura, T; Nakamura, M; Sonomoto, K; Suematsu, E; Takahama, S; Yamamoto, M, 2010) |
"Between 20% and 40% of patients with systemic lupus erythematosus (SLE) have positive blood tests for antiphospholipid antibodies (aPLs)." | 1.35 | How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. ( Giles, I; Rahman, A, 2009) |
"Autoimmune diseases are a group of illnesses in which autoantibodies are produced against various organs, presenting with a variety of clinical symptoms." | 1.32 | Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. ( Chen, L; Miller, RK; Ornoy, A; Silver, RM, 2004) |
"An 18-year-old Saudi male with systemic lupus erythematosus (SLE) presented with mild right hemiparesis, followed by recurrent ischemic stroke." | 1.31 | Systemic lupus erythematosus associated with moyamoya syndrome. ( Al Rayes, HM; El Ramahi, KM, 2000) |
"Pregnancy was authorized if disease was inactive on 20 mg/day prednisone or less for at least 1 yr." | 1.30 | Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. ( Blétry, O; Darbois, Y; Godeau, P; Lê Huong, D; Lefèbvre, G; Piette, JC; Seebacher, J; Vauthier-Brouzes, D; Wechsler, B, 1997) |
"The rate of recurrence of thrombosis was highest (1." | 1.29 | The management of thrombosis in the antiphospholipid-antibody syndrome. ( Cuadrado, MJ; Hughes, GR; Hunt, BJ; Khamashta, MA; Mujic, F; Taub, NA, 1995) |
"Five warfarin-treated patients had five significant bleeding events (0." | 1.28 | Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. ( Brewer, PM; Rosove, MH, 1992) |
"Eight patients, 3 with systemic lupus erythematosus (SLE) or "SLE-like" disease, 1 with sarcoidosis, and 4 with no connective tissue disease had transient ischemic attacks (TIA) or cerebral infarctions associated with high levels of anticardiolipin antibodies (ACA)." | 1.28 | Cerebral ischemia associated with anticardiolipin antibodies. ( Ernerudh, J; Lindström, F; Olsson, JE; Vrethem, M, 1992) |
"Two patients had systemic lupus erythematosus, and the other five fulfilled criteria for the primary antiphospholipid syndrome." | 1.28 | Fetal loss treatment in patients with antiphospholipid antibodies. ( Barquinero, J; Genover, E; Jordana, R; Ordi, J; Selva, A; Tolosa, C; Vilardell, M, 1989) |
"After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 1.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
"The hyperkalemia was disproportionate to the degree of renal excretory impairment." | 1.27 | Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus. ( Kiley, J; Zager, P, 1984) |
"A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women." | 1.27 | Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984) |
"In whole blood from 30 patients with systemic lupus erythematosus (SLE), 10 normal subjects, and 40 patients with active seropositive rheumatoid arthritis (RA), there were negative correlations between the hematocrit level and the ASA half-life in vitro: r = -0." | 1.27 | Patterns of in vitro aspirin hydrolysis rates in rheumatoid arthritis and systemic lupus erythematosus. ( Costello, PB; Green, FA, 1986) |
"This report describes two cases of systemic lupus erythematosus (SLE) treated with immunosuppressive agents." | 1.27 | Acute granulocytic leukemia following systemic lupus erythematosus. ( Goldberg, J; Paolozzi, FP, 1985) |
"A 14-year-old girl in whom Reye syndrome developed during aspirin therapy for an inflammatory disorder proven to be systemic lupus erythematosus is reported." | 1.27 | Reye syndrome associated with aspirin therapy for systemic lupus erythematosus. ( Bale, JF; Corbett, AJ; Flanders, DJ; Hansen, JR; McCray, PB, 1985) |
"The charts of 238 patients with systemic lupus erythematosus (SLE) were reviewed." | 1.26 | The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. ( Anuras, S; LaBrecque, DR; Runyon, BA, 1980) |
"Aspirin was discontinued and ibuprofen, 600 mg four times daily, begun." | 1.26 | Aspirin hepatotoxicity. ( Hindin, BI; Kanada, SA; Kolling, WM, 1978) |
"Approximately 8% of patients with systemic lupus erythematosus have drug induced disease." | 1.26 | [New aspects of drug induced lupus erythematosus (author's transl)]. ( Robinson, HM, 1978) |
"In 13 of 23 patients with systemic lupus erythematosus increases in serum creatinine ranged from 27 to 163 per cent, and those in urea nitrogen from 42 to 270 per cent." | 1.26 | Aspirin-induced depression of renal function. ( Kimberly, RP; Plotz, PH, 1977) |
"The existence of hepatic involvement in systemic lupus erythematosus (SLE) is still contested in the literature." | 1.26 | Hepatic involvement in systemic lupus erythematosus. A case report. ( Forman, MB; Gear, AJ; Levy, H; Ninin, DT, 1981) |
"A patient with systemic lupus erythematosus presented with moderately severe restrictive and obstructive ventilatory defects." | 1.26 | Pulmonary function abnormalities in systemic lupus erythematosus responsive to glucocorticoid therapy. ( Al-Bazzaz, F; Venizelos, PC, 1981) |
"Hallucinations were either unformed (for example, bright lights, straight lines) or highly formed (for example, faces), in which case they were invariably recognized by the patient as inappropriate." | 1.25 | Cerebral disorders of vision in systemic lupus erythematosus. ( Brandt, KD; Cohen, AS; Lessell, S, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 79 (39.70) | 18.7374 |
1990's | 24 (12.06) | 18.2507 |
2000's | 41 (20.60) | 29.6817 |
2010's | 45 (22.61) | 24.3611 |
2020's | 10 (5.03) | 2.80 |
Authors | Studies |
---|---|
Sairam, S | 1 |
Sureen, A | 1 |
Gutierrez, J | 1 |
Dang, TQ | 1 |
Mishra, K | 1 |
Udry, S | 1 |
Peréz, SM | 1 |
Belizna, C | 1 |
Aranda, F | 1 |
Esteve-Valverde, E | 1 |
Wingeyer, SP | 1 |
Fernández-Romero, DS | 1 |
Latino, JO | 1 |
de Larrañaga, G | 1 |
Alijotas-Reig, J | 3 |
Tani, C | 1 |
Zucchi, D | 1 |
Haase, I | 1 |
Gerosa, M | 2 |
Larosa, M | 1 |
Cavagna, L | 1 |
Bortoluzzi, A | 1 |
Crisafulli, F | 1 |
Mucke, J | 1 |
Strigini, FAL | 1 |
Baglietto, L | 1 |
Fornili, M | 1 |
Monacci, F | 1 |
Elefante, E | 1 |
Erra, R | 1 |
Bellis, E | 1 |
Padovan, M | 1 |
Andreoli, L | 3 |
Coletto, LA | 1 |
Zanframundo, G | 1 |
Govoni, M | 1 |
Iaccarino, L | 1 |
Tincani, A | 6 |
Doria, A | 2 |
Fischer-Betz, R | 1 |
Mosca, M | 4 |
Silver, R | 1 |
Craigo, S | 1 |
Porter, F | 1 |
Osmundson, SS | 1 |
Kuller, JA | 1 |
Norton, ME | 1 |
Zhang, N | 3 |
Zhang, HX | 3 |
Li, YW | 3 |
Li, Y | 4 |
Tao, JJ | 1 |
Adurty, S | 1 |
D'Angelo, D | 1 |
DeSancho, MT | 1 |
Chen, X | 2 |
Di, W | 1 |
Ye, L | 1 |
Hu, Y | 1 |
Jiang, M | 1 |
Wu, J | 1 |
Bu, J | 1 |
Sun, J | 1 |
Bei, F | 1 |
Eudy, AM | 1 |
Voora, D | 1 |
Myers, RA | 1 |
Clowse, MEB | 1 |
Mueller, AA | 1 |
Vaidya, A | 1 |
Tarter, LL | 1 |
Klein, JP | 1 |
Barkoudah, E | 1 |
Chavatza, K | 1 |
Kostopoulou, M | 1 |
Nikolopoulos, D | 1 |
Gioti, O | 1 |
Togia, K | 1 |
Aringer, M | 1 |
Boletis, J | 1 |
Houssiau, FA | 1 |
Jayne, D | 1 |
Svenungsson, E | 1 |
Bertsias, G | 1 |
Fanouriakis, A | 1 |
Boumpas, DT | 1 |
Li, X | 1 |
Shopit, A | 1 |
Wang, J | 1 |
Vinay, K | 1 |
Sawatkar, G | 1 |
Dogra, S | 1 |
Saikia, UN | 1 |
Fasano, S | 3 |
Pierro, L | 2 |
Pantano, I | 3 |
Iudici, M | 2 |
Valentini, G | 3 |
Riancho-Zarrabeitia, L | 1 |
Daroca, G | 1 |
Muñoz, P | 1 |
López-Hoyos, M | 1 |
Haya, A | 1 |
Martínez-Taboada, VM | 1 |
Margiotta, DP | 1 |
Navarini, L | 1 |
Riccardi, A | 1 |
Afeltra, A | 1 |
Mahajan, K | 1 |
Negi, P | 1 |
Merwaha, R | 1 |
Sharma, M | 1 |
Kötter, I | 1 |
Stübiger, N | 1 |
Deuter, C | 1 |
Nkeck, JR | 1 |
Endomba, FTA | 1 |
Ndoadoumgue, AL | 1 |
Kalbassou, FB | 1 |
Chen, WL | 1 |
Liu, YD | 1 |
Li, XL | 1 |
Feng, SX | 1 |
Zhou, XY | 1 |
Ma, WX | 1 |
Ye, DS | 1 |
Chen, SL | 1 |
Mazur-Nicorici, L | 1 |
Sadovici-Bobeica, V | 1 |
Garabajiu, M | 1 |
Mazur, M | 1 |
de Moreuil, C | 1 |
Fauchais, AL | 1 |
Merviel, P | 1 |
Tremouilhac, C | 1 |
Le Moigne, E | 1 |
Pasquier, E | 1 |
Pan-Petesch, B | 1 |
Lacut, K | 1 |
Quintanilla-González, L | 1 |
Torres-Villalobos, G | 1 |
Hinojosa-Azaola, A | 1 |
Mendel, A | 1 |
Bernatsky, SB | 1 |
Hanly, JG | 1 |
Urowitz, MB | 2 |
Clarke, AE | 1 |
Romero-Diaz, J | 1 |
Gordon, C | 2 |
Bae, SC | 1 |
Wallace, DJ | 1 |
Merrill, JT | 2 |
Buyon, JP | 2 |
Isenberg, DA | 2 |
Rahman, A | 3 |
Ginzler, EM | 1 |
Petri, M | 3 |
Dooley, MA | 1 |
Fortin, PR | 1 |
Gladman, DD | 2 |
Steinsson, K | 1 |
Ramsey-Goldman, R | 2 |
Khamashta, MA | 7 |
Aranow, C | 1 |
Mackay, M | 1 |
Alarcón, GS | 1 |
Manzi, S | 2 |
Nived, O | 1 |
Jönsen, A | 1 |
Zoma, AA | 1 |
van Vollenhoven, RF | 1 |
Ramos-Casals, M | 1 |
Ruiz-Irastorza, G | 5 |
Lim, S | 1 |
Kalunian, KC | 1 |
Inanc, M | 1 |
Kamen, DL | 1 |
Peschken, CA | 1 |
Jacobsen, S | 1 |
Askanase, A | 1 |
Sanchez-Guerrero, J | 1 |
Bruce, IN | 2 |
Costedoat-Chalumeau, N | 2 |
Vinet, É | 1 |
Christodoulou, C | 1 |
Economides, C | 1 |
D'Cruz, D | 1 |
Akdogan, A | 1 |
Kilic, L | 1 |
Akman, U | 1 |
Dogan, I | 1 |
Karadag, O | 1 |
Bilgen, SA | 1 |
Buyukasik, Y | 1 |
Kiraz, S | 1 |
Ertenli, I | 1 |
Kawai, VK | 1 |
Avalos, I | 2 |
Oeser, A | 2 |
Oates, JA | 1 |
Milne, GL | 2 |
Solus, JF | 1 |
Chung, CP | 2 |
Stein, CM | 2 |
Cuadrado, MJ | 2 |
Bertolaccini, ML | 1 |
Seed, PT | 1 |
Tektonidou, MG | 2 |
Aguirre, A | 1 |
Mico, L | 1 |
Egurbide, MV | 1 |
Gil, A | 1 |
Espinosa, G | 1 |
Houssiau, F | 1 |
Martin, H | 1 |
McHugh, N | 1 |
Galindo, M | 1 |
Akil, M | 1 |
Amigo, MC | 1 |
Murru, V | 1 |
Arnaud, L | 1 |
Mathian, A | 1 |
Ruffatti, A | 3 |
Erkan, D | 1 |
Tektonidou, M | 1 |
Cervera, R | 3 |
Forastiero, R | 1 |
Pengo, V | 2 |
Lambert, M | 2 |
Martinez-Zamora, MA | 1 |
Balasch, J | 1 |
Zuily, S | 1 |
Wahl, D | 2 |
Amoura, Z | 1 |
Yasuda, S | 1 |
Salvan, E | 1 |
Del Ross, T | 1 |
Maina, A | 1 |
De Carolis, S | 2 |
Mekinian, A | 1 |
Bertero, MT | 2 |
Canti, V | 2 |
Brucato, A | 1 |
Bremme, K | 1 |
Ramoni, V | 1 |
Di Poi, E | 1 |
Caramaschi, P | 1 |
Galeazzi, M | 1 |
Trespidi, L | 1 |
Meroni, PL | 2 |
Jung, JY | 1 |
Koh, BR | 1 |
Bae, CB | 1 |
Kim, HA | 1 |
Suh, CH | 1 |
Ramcharan, K | 1 |
Abdool, K | 1 |
Persad, N | 1 |
Dyaanand, H | 1 |
Sciascia, S | 1 |
Branch, DW | 2 |
Levy, RA | 1 |
Middeldorp, S | 1 |
Pavord, S | 1 |
Roccatello, D | 1 |
Khamashta, M | 2 |
Schreiber, K | 1 |
Hunt, BJ | 3 |
Kim, MY | 1 |
Guerra, MM | 1 |
Rana, S | 1 |
Zhang, D | 1 |
Laskin, CA | 1 |
Lockshin, MD | 2 |
Sammaritano, LR | 1 |
Porter, TF | 1 |
Stephenson, MD | 1 |
Gao, Q | 1 |
Karumanchi, SA | 1 |
Salmon, JE | 1 |
Kattah, AG | 1 |
Garovic, VD | 1 |
Moroni, G | 1 |
Ponticelli, C | 1 |
Gabriele Falcone, L | 1 |
La Montagna, G | 1 |
Migliaresi, S | 1 |
Abheiden, CN | 1 |
Blomjous, BS | 1 |
Kroese, SJ | 1 |
Bultink, IE | 1 |
Fritsch-Stork, RD | 1 |
Lely, AT | 1 |
de Boer, MA | 1 |
de Vries, JI | 1 |
Puri, PK | 1 |
Lountzis, NI | 1 |
Tyler, W | 1 |
Ferringer, T | 1 |
Laskari, K | 1 |
Panagiotakos, DB | 1 |
Moutsopoulos, HM | 1 |
Koren, G | 1 |
Kroshinsky, D | 1 |
Stone, JH | 1 |
Bloch, DB | 1 |
Sepehr, A | 1 |
Escárcega, RO | 1 |
Garcia-Carrasco, M | 1 |
Jara, LJ | 1 |
Giles, I | 1 |
Horai, Y | 1 |
Miyamura, T | 1 |
Takahama, S | 1 |
Sonomoto, K | 1 |
Nakamura, M | 1 |
Ando, H | 1 |
Minami, R | 1 |
Yamamoto, M | 1 |
Suematsu, E | 1 |
Lim, W | 1 |
Dönmez, O | 1 |
Durmaz, O | 1 |
Kouprianoff, S | 1 |
Chiquet, C | 1 |
Bouillet, L | 1 |
Romanet, JP | 1 |
Doi, H | 1 |
Tateishi, T | 1 |
Isobe, N | 1 |
Yamasaki, R | 1 |
Ohyagi, Y | 1 |
Kira, J | 1 |
Haddad, F | 1 |
Anouti, S | 1 |
Maalouly, G | 1 |
Koussa, S | 1 |
Dang Do, AN | 1 |
Umoren, RA | 1 |
Tarvin, SE | 1 |
Heilbrunn, BR | 1 |
Mahajerin, A | 1 |
Bowyer, SL | 1 |
Defelice, T | 1 |
Lu, P | 1 |
Loyd, A | 1 |
Patel, R | 1 |
Franks, AG | 1 |
Ishaq, S | 1 |
Khalil, S | 1 |
Khan, A | 1 |
Khalid, U | 1 |
Patel, PJ | 1 |
Matthai, WH | 1 |
Untereker, WJ | 1 |
Tonello, M | 1 |
Visentin, MS | 1 |
Bontadi, A | 1 |
Hoxha, A | 1 |
Botta, A | 1 |
Salvi, S | 1 |
Nuzzo, M | 1 |
Rovere-Querini, P | 1 |
Mitic, G | 1 |
Boffa, MC | 2 |
Wójtowicz, A | 1 |
Undas, A | 1 |
Huras, H | 1 |
Musiał, J | 1 |
Rytlewski, K | 1 |
Reroń, A | 1 |
Wilczak, M | 1 |
Jach, R | 1 |
Saadoun, D | 1 |
Piette, JC | 4 |
Tarr, T | 2 |
Kiss, E | 2 |
Szegedi, G | 2 |
Zeher, M | 1 |
Bhavsar, SV | 1 |
White, CM | 1 |
Fifi-Mah, A | 1 |
Yazbek, MA | 1 |
Velho, P | 1 |
Nadruz, W | 1 |
Mahayri, N | 1 |
Appenzeller, S | 1 |
Costallat, LT | 1 |
Specker, Ch | 1 |
Arvieux, J | 1 |
Hachulla, E | 2 |
Magy, N | 1 |
Gil, H | 1 |
Racadot, E | 1 |
Dupond, JL | 1 |
Alarcón-Segovia, D | 3 |
Branch, W | 1 |
Gharavi, A | 1 |
Shoenfeld, Y | 5 |
Wilson, W | 1 |
Roubey, R | 1 |
IRBY, R | 1 |
COSSERMELLI, W | 1 |
BABB, RR | 1 |
FAIRBAIRN, JF | 1 |
POLLOCK, J | 1 |
STRITZLER, R | 1 |
TUFFANELLI, DL | 1 |
DUBOIS, EL | 1 |
VANCAUWENBERGE, H | 1 |
FRANCHIMONT, P | 1 |
LAMBERT, PH | 1 |
LAPIERE, CM | 1 |
LEFEBVRE, P | 1 |
LISIN, N | 1 |
SALMON, J | 1 |
BARTHOLOMEW, LE | 1 |
Au, A | 1 |
O'Day, J | 1 |
Gromnica-Ihle, E | 1 |
Ornoy, A | 1 |
Chen, L | 1 |
Silver, RM | 1 |
Miller, RK | 1 |
Cistero-Bahima, A | 1 |
Chen, HC | 1 |
Lai, JH | 1 |
Huang, GS | 1 |
Gao, HW | 1 |
Chen, CH | 1 |
Kuo, SY | 1 |
Chang, DM | 1 |
McLaurin, EY | 1 |
Holliday, SL | 1 |
Williams, P | 1 |
Brey, RL | 1 |
Soy, M | 1 |
Sayin, NC | 1 |
Unlü, E | 1 |
Bonaminio, PN | 1 |
de Regnier, R | 1 |
Chang, E | 1 |
Day, N | 1 |
Costenbader, KH | 1 |
Karlson, EW | 1 |
Gall, V | 1 |
de Pablo, P | 1 |
Finckh, A | 1 |
Lynch, M | 1 |
Bermas, B | 1 |
Schur, PH | 1 |
Liang, MH | 1 |
Olivier, AC | 1 |
Hollman, JL | 1 |
Kornacka, MK | 1 |
Bokiniec, R | 1 |
Skrzypczak, J | 1 |
Lakos, G | 1 |
Bhattoa, HP | 1 |
Soltesz, P | 1 |
Borntrager, H | 1 |
Morrow, JD | 1 |
Raggi, P | 1 |
Solus, J | 1 |
Hereng, T | 1 |
Samor, M | 1 |
Dubucquoi, S | 1 |
Caron, C | 1 |
Launay, D | 1 |
Morell-Dubois, S | 1 |
Queyrel, V | 1 |
Hatron, PY | 1 |
Trakakis, E | 1 |
Loghis, C | 1 |
Laggas, D | 1 |
Simeonides, G | 1 |
Vaggopoulos, V | 1 |
Chrelias, C | 1 |
Lambos, G | 1 |
Kassanos, D | 1 |
Perricone, R | 1 |
De Carolis, C | 1 |
Kröegler, B | 1 |
Greco, E | 1 |
Giacomelli, R | 1 |
Cipriani, P | 1 |
Fontana, L | 1 |
Perricone, C | 1 |
Calabro, JJ | 5 |
Marchesano, JM | 2 |
Kantor, TG | 1 |
Lubbe, WF | 3 |
Butler, WS | 2 |
Palmer, SJ | 2 |
Liggins, GC | 3 |
Schlumberger, HD | 1 |
Hughes, GR | 4 |
Syrop, CH | 1 |
Varner, MW | 1 |
Kiley, J | 1 |
Zager, P | 1 |
Furst, DE | 1 |
Glavinskaia, TA | 2 |
Novikov, AI | 1 |
Pavlova, LT | 1 |
Karsh, J | 1 |
Kimberly, RP | 5 |
Stahl, NI | 1 |
Plotz, PH | 5 |
Decker, JL | 1 |
Rasmussen, S | 1 |
Petersen, J | 1 |
Nielsen, IL | 1 |
Christensen, P | 1 |
Hilden, T | 1 |
Clark, WF | 1 |
Tevaarwerk, GJ | 1 |
Moriarity, TA | 1 |
Reid, BD | 1 |
Feng, PH | 1 |
Forman, MB | 1 |
Levy, H | 1 |
Gear, AJ | 1 |
Ninin, DT | 1 |
Venizelos, PC | 1 |
Al-Bazzaz, F | 1 |
Wasner, CK | 1 |
Fries, JF | 1 |
Runyon, BA | 1 |
LaBrecque, DR | 1 |
Anuras, S | 1 |
Zimmerman, HJ | 1 |
Ogasawara, M | 1 |
Aoki, K | 1 |
Hayashi, Y | 1 |
Mujic, F | 1 |
Taub, NA | 1 |
Rivier, G | 1 |
Herranz, MT | 1 |
Ferris, AM | 1 |
Reece, EA | 1 |
Stuart, RA | 1 |
Quinn, MJ | 1 |
McHugh, NJ | 1 |
Kaaja, R | 2 |
Julkunen, H | 2 |
Ammälä, P | 1 |
Palosuo, T | 1 |
Kurki, P | 1 |
Viinikka, L | 1 |
Ylikorkala, O | 1 |
Chakravarty, K | 1 |
Merry, P | 1 |
Fishman, P | 1 |
Falach-Vaknin, E | 1 |
Sredni, B | 1 |
Dicker, D | 1 |
Lê Huong, D | 1 |
Wechsler, B | 3 |
Vauthier-Brouzes, D | 1 |
Seebacher, J | 1 |
Lefèbvre, G | 1 |
Blétry, O | 2 |
Darbois, Y | 1 |
Godeau, P | 1 |
Ferro, D | 1 |
Basili, S | 1 |
Roccaforte, S | 1 |
Di Franco, M | 1 |
Cipollone, F | 1 |
Ciabattoni, G | 1 |
Davì, G | 1 |
Le Thi Huong, D | 1 |
Wahl, DG | 1 |
Bounameaux, H | 1 |
de Moerloose, P | 1 |
Sarasin, FP | 1 |
Rees, AH | 1 |
Malaviya, AN | 1 |
Mourou, M | 1 |
El Ramahi, KM | 1 |
Al Rayes, HM | 1 |
Joseph, JE | 1 |
Harrison, P | 1 |
Mackie, IJ | 1 |
Machin, SJ | 1 |
Lee, SC | 1 |
Kim, DH | 1 |
Won, YH | 1 |
Komócsi, A | 1 |
Tóvari, E | 1 |
Pajor, L | 1 |
Czirják, L | 1 |
Pauzner, R | 1 |
Dulitzki, M | 1 |
Langevitz, P | 1 |
Livneh, A | 1 |
Kenett, R | 1 |
Many, A | 2 |
Jerzak, MM | 1 |
Prusek, W | 1 |
Podwysocka, M | 1 |
Goluda, M | 1 |
Bienenstock, H | 1 |
Fernando, KR | 1 |
Bulmash, JM | 1 |
Keystone, EC | 1 |
Kanada, SA | 1 |
Kolling, WM | 1 |
Hindin, BI | 1 |
Bowie, EJ | 1 |
Owen, CA | 1 |
Gillett, DG | 1 |
Ford, GT | 1 |
Szczeklik, A | 1 |
Gryglewski, RJ | 1 |
Czerniawska-Mysik, G | 1 |
DiSabatino, CA | 1 |
Clyne, LP | 1 |
Malawista, SE | 1 |
Robinson, HM | 1 |
Gill, JR | 1 |
Bowden, RE | 1 |
Keiser, HR | 1 |
Travers, RL | 1 |
Halla, JT | 1 |
Sack, KE | 1 |
Rosenthal, SH | 1 |
Zernov, VP | 1 |
Ostroumova, TN | 1 |
Brandt, KD | 1 |
Lessell, S | 1 |
Cohen, AS | 1 |
Zucker, P | 1 |
Daum, F | 1 |
Cohen, MI | 1 |
Beall, CL | 1 |
Pierce, LE | 1 |
Birdsall, M | 1 |
Pattison, N | 1 |
Chamley, L | 1 |
De Leeuw, P | 1 |
Lefebvre, C | 1 |
Tomasi, JP | 1 |
Rahier, J | 1 |
Geubel, A | 1 |
Laraki, R | 1 |
Cosserat, J | 1 |
Kobayashi, S | 1 |
Tamura, N | 1 |
Tsuda, H | 1 |
Mokuno, C | 1 |
Hashimoto, H | 1 |
Hirose, S | 1 |
Landy, HJ | 1 |
Kessler, C | 1 |
Kelly, WK | 1 |
Weingold, AB | 1 |
Rosove, MH | 1 |
Brewer, PM | 1 |
Vrethem, M | 1 |
Ernerudh, J | 1 |
Lindström, F | 1 |
Olsson, JE | 1 |
Barton, JR | 1 |
Sibai, BM | 1 |
Memon, S | 1 |
Rab, SM | 1 |
Keirse, MJ | 1 |
Sumiya, M | 1 |
Ordi, J | 1 |
Barquinero, J | 1 |
Vilardell, M | 1 |
Jordana, R | 1 |
Tolosa, C | 1 |
Selva, A | 1 |
Genover, E | 1 |
Gatenby, PA | 1 |
Cameron, K | 1 |
Shearman, RP | 1 |
Carp, HJ | 1 |
Frenkel, Y | 1 |
Menashe, Y | 1 |
Mashiach, S | 1 |
Nebel, L | 1 |
Toder, V | 1 |
Serr, DM | 1 |
Elder, MG | 1 |
de Swiet, M | 1 |
Robertson, A | 1 |
Elder, MA | 1 |
Flloyd, E | 1 |
Hawkins, DF | 1 |
Druzin, ML | 1 |
Qamar, T | 1 |
Cohen de Lara, A | 1 |
Costello, PB | 1 |
Green, FA | 1 |
Paolozzi, FP | 1 |
Goldberg, J | 1 |
Hansen, JR | 1 |
McCray, PB | 1 |
Bale, JF | 1 |
Corbett, AJ | 1 |
Flanders, DJ | 1 |
Lee, P | 1 |
Foad, BS | 1 |
Sheon, RP | 1 |
Kirsner, AB | 1 |
Rosenow, EC | 1 |
Richards, AJ | 1 |
Gordon, DA | 1 |
Kraag, G | 1 |
Katz, RM | 1 |
Maltz, BA | 1 |
Reeves, WG | 1 |
Trounce, JR | 1 |
Cosh, JA | 1 |
Baker, M | 1 |
Steinberg, AD | 1 |
Boone, JE | 1 |
Baldwin, J | 1 |
Levine, C | 1 |
Winckelmann, G | 1 |
Seaman, WE | 1 |
Ishak, KG | 1 |
Wolfe, JD | 1 |
Metzger, AL | 1 |
Goldstein, RC | 1 |
Ramirez-Mata, M | 1 |
Reyes, PA | 1 |
Garza, R | 1 |
Goldenberg, DL | 1 |
Hilton, AM | 1 |
Dymock, IW | 1 |
Rothfield, NF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Vascular Damage in Systemic Lupus Erythematosus (SLE)[NCT00731302] | Phase 1 | 70 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
A Multicenter, Double-blind, Randomized and Parallel Controlled Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Miscarriage With Antiphospholipid Syndrome[NCT04624269] | Phase 4 | 384 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)[NCT00198068] | 700 participants (Anticipated) | Observational | 2003-09-30 | Recruiting | |||
A Randomized Controlled Trial of Strategies for the Prevention of Accelerated Atherosclerosis in Systemic Lupus Erythematosus - A Pilot Study[NCT00054938] | Phase 2 | 150 participants | Interventional | 2003-03-31 | Completed | ||
Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE)[NCT05995600] | Phase 4 | 400 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
Apixaban for the Secondary Prevention of Thromboembolism: a Prospective Randomized Outcome Pilot Study Among Patients With the AntiphosPholipid Syndrome[NCT02295475] | Phase 4 | 48 participants (Actual) | Interventional | 2014-12-10 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
47 reviews available for aspirin and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Cardiovascular Outcomes in Systemic Lupus Erythematosus.
Topics: Aspirin; Cardiovascular Diseases; Disease Progression; Humans; Inflammation; Lupus Erythematosus, Sy | 2022 |
Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2021 |
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Cardiovascular Diseases; Female; Humans; Hydroxychloro | 2017 |
[Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis, Rheumatoid; Aspirin; Collagen Diseases; Cross-Sec | 2017 |
[Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?]
Topics: Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Pre-Eclampsia; Precision Medicine; Pregnancy | 2018 |
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Hemorrhage; Humans; Lupus Erythema | 2014 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome].
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2013 |
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Female; Heparin; H | 2016 |
Pregnancy and Lupus Nephritis.
Topics: Abortion, Spontaneous; Anticoagulants; Antihypertensive Agents; Antiphospholipid Syndrome; Aspirin; | 2015 |
Pregnancy in women with systemic lupus erythematosus (SLE).
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspi | 2016 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Blood Transfus | 2009 |
Lupus and pregnancy: integrating clues from the bench and bedside.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseli | 2011 |
[Management of antiphospholipid syndrome].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; As | 2012 |
[Antiphospholipid-syndrome - when to treat?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; As | 2012 |
[Antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Femal | 2002 |
Prophylaxis of the antiphospholipid syndrome: a consensus report.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; P | 2003 |
Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Combined Mo | 2004 |
Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto's disease complicated with antiphospholipid antibody syndrome: a case report and review of the literature.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; An | 2005 |
Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?
Topics: Animals; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Humans; Hydroxymethylglutaryl- | 2005 |
[Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy].
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Disease Progression; Female; Humans; Immunosuppr | 2006 |
[Newborn from mother with antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Female; Fet | 2006 |
[Fetus monitoring of a mother suffering from the antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female | 2006 |
Pseudo-allergic reactions to drugs and chemicals.
Topics: Anaphylaxis; Aspirin; Complement Activation; Complement System Proteins; Cyclooxygenase Inhibitors; | 1983 |
The treatment of SLE: the case of conservative management.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antimalarials; Arthriti | 1982 |
Systemic lupus erythematosus.
Topics: Abnormalities, Drug-Induced; Abortion, Therapeutic; Adrenal Cortex Hormones; Aspirin; Azathioprine; | 1983 |
Acute effects of aspirin and acetaminophen on renal function.
Topics: Acetaminophen; Aspirin; Humans; Indomethacin; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Lupu | 1981 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; A | 1994 |
Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes.
Topics: Adult; Aspirin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Humans; Lactation Disorders; | 1994 |
[Effect of pregnancy, menopause and hormone substitution therapy on disseminated systemic lupus erythematosus].
Topics: Aspirin; Estrogen Replacement Therapy; Female; Heparin; Humans; Lupus Erythematosus, Systemic; Ovula | 2000 |
Pediatric autoimmune cardiovascular disease.
Topics: Adolescent; Antibodies, Antinuclear; Aspirin; Autoimmune Diseases; Child; Child, Preschool; Coronary | 2000 |
Management of thrombosis in antiphospholipid antibody syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Hemorrhage; Heparin; Humans; Lupus Erythematosus | 2001 |
Histiocytic necrotizing lymphadenitis preceding systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Biopsy, Needle; Cyclophosphamide; Diagnosis, Differential; | 2001 |
Arthritis in the elderly. An overview.
Topics: Adolescent; Adult; Aged; Aging; Anti-Inflammatory Agents; Arthritis; Arthritis, Infectious; Arthriti | 1976 |
Systemic lupus erythematosus and pregnancy.
Topics: Antimalarials; Aspirin; Autoantibodies; B-Lymphocytes; Complement System Proteins; Female; Glucocort | 1978 |
Hemostatic failure in clinical medicine.
Topics: Acute Disease; Amyloidosis; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Vessels; Chroni | 1977 |
Drug-induced lung disease.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Aspirin; Bronchial Spasm; Eosinophilia; Human | 1978 |
Aspirin, liver, and rheumatic diseases.
Topics: Adolescent; Adult; Arthritis, Juvenile; Arthritis, Rheumatoid; Aspirin; Chemical and Drug Induced Li | 1976 |
Rheumatoid arthritis: an overview.
Topics: Adult; Arthritis; Arthritis, Reactive; Arthritis, Rheumatoid; Aspirin; Diagnosis, Differential; Fema | 1976 |
[Role of antiphospholipid antibodies in fetal loss].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Antibodies, Antiphospho | 1992 |
Low-dose aspirin to improve perinatal outcome.
Topics: Antibodies; Aspirin; Blood Coagulation Factors; Cardiolipins; Female; Fetal Growth Retardation; Fetu | 1991 |
Lupus anticoagulant and pregnancy.
Topics: Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Fetal Death; Fetal Diseases; Fetal Growt | 1985 |
The spectrum of drug-induced pulmonary disease.
Topics: Adrenal Cortex Hormones; Aerosols; Analgesics; Aspirin; Autonomic Agents; Bleomycin; Busulfan; Contr | 1972 |
A critical reappraisal of juvenile rheumatoid arthritis.
Topics: Agammaglobulinemia; Arthritis, Juvenile; Aspirin; Cardiomegaly; Child; Child, Preschool; Chloroquine | 1971 |
An approach to the use of immunosuppressive drugs in nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Chlorambucil; Cyclophosphamide; G | 1973 |
Juvenile rheumatoid arthritis.
Topics: Antibodies, Antinuclear; Antimalarials; Arthritis, Juvenile; Aspirin; Blood Sedimentation; Child; Co | 1974 |
[Blood platelet diseases].
Topics: Adenosine Diphosphate; Afibrinogenemia; Aspirin; Blood Platelet Disorders; Blood Platelets; Diagnosi | 1973 |
Rheumatoid arthritis. A potentially crippling disease that may attack at any age.
Topics: Adrenal Cortex Hormones; Agammaglobulinemia; Age Factors; Analgesics; Antimalarials; Arthritis, Juve | 1971 |
11 trials available for aspirin and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome.
Topics: Adult; Aspirin; Biomarkers; Blood Platelets; C-Reactive Protein; Chi-Square Distribution; Cyclooxyge | 2014 |
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune | 2014 |
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Aspirin; Drug Therapy, Combinat | 2005 |
Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus.
Topics: Adult; Aspirin; Cyclooxygenase Inhibitors; Drug Resistance; Epoprostenol; Female; Humans; Lupus Eryt | 2007 |
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antibodies | 2008 |
Comparative effects of aspirin and ibuprofen in the management of systemic lupus erythematosus.
Topics: Aspirin; Clinical Trials as Topic; Humans; Ibuprofen; Lupus Erythematosus, Systemic; Placebos; Resea | 1980 |
Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments.
Topics: Adolescent; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 1994 |
Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Chromatography, High Pressure Liquid; Epoprostenol; Fe | 1993 |
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
Topics: Adult; Antibodies, Antiphospholipid; Antigens; Aspirin; Cross-Sectional Studies; Dose-Response Relat | 1999 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 2001 |
Psychopathology in systemic lupus erythematosus. I. Psychiatric observations.
Topics: Adolescent; Adult; Affective Symptoms; Aspirin; Azathioprine; Brain Diseases; Clinical Trials as Top | 1973 |
141 other studies available for aspirin and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; P | 2022 |
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study.
Topics: Aspirin; Female; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Pre-Eclampsia; Pregnancy; P | 2022 |
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Wei | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Management and outcomes of women with antiphospholipid syndrome during pregnancy.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; | 2023 |
Association of preterm outcome with maternal systemic lupus erythematosus: a retrospective cohort study.
Topics: Aspirin; Birth Weight; Child; China; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Lup | 2023 |
Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.
Topics: Adult; Aspirin; Female; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Lupu | 2019 |
Caught in a Flare.
Topics: Arthralgia; Aspirin; Atorvastatin; Brain; Diagnosis, Differential; Exanthema; Fatigue; Female; Hemat | 2020 |
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antirheumatic Agents; Aspirin; Drug Tapering; Europe; Fema | 2021 |
Systemic lupus erythematosus with Degos disease: role of dermatoscopy in diagnosis.
Topics: Adolescent; Aspirin; Biopsy, Needle; Dermoscopy; Drug Therapy, Combination; Female; Humans; Hydroxyc | 2017 |
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Topics: Adult; Antirheumatic Agents; Aspirin; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combina | 2017 |
Serological evolution in women with positive antiphospholipid antibodies.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; | 2017 |
Isolated tricuspid valve Libman-Sacks endocarditis in a patient with antiphospholipid antibody syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Echocardiography; Endocarditis; Female; H | 2017 |
Gangrene of All Digits and Toes Attributable to Systemic Lupus Erythematosus With Negative Antiphospholipid Antibodies.
Topics: Adult; Amputation, Surgical; Antibodies, Antiphospholipid; Aspirin; Female; Fingers; Follow-Up Studi | 2019 |
[Pregnancy outcome in a woman with premature ovarian insufficiency complicated by systemic lupus erythematosus during pregnancy: a case report].
Topics: Aspirin; Cesarean Section; Embryo Transfer; Female; Fertilization in Vitro; Humans; Lupus Erythemato | 2017 |
Therapeutic adherence in patients with systemic lupus erythematosus: a cross-sectional study.
Topics: Adolescent; Adult; Age of Onset; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Secti | 2018 |
Risk factors for development of early infectious and noninfectious complications in systemic lupus erythematosus patients undergoing major surgery.
Topics: Adolescent; Adult; Aged; Anemia; Aspirin; Child; Elective Surgical Procedures; Female; Humans; Logis | 2018 |
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Platelet Agg | 2019 |
Critical reversible bilateral internal carotid artery stenosis associated with SLE.
Topics: Adult; Antirheumatic Agents; Aspirin; Carotid Stenosis; Drug Therapy, Combination; Female; Glucocort | 2013 |
Aspirin resistance in systemic lupus erythematosus. A pilot study.
Topics: Adult; Antibodies, Anticardiolipin; Aspirin; Case-Control Studies; Drug Resistance; Electric Impedan | 2013 |
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Europe; Female; Heparin; Hu | 2014 |
Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; B | 2014 |
Movement disorders in systemic lupus erythematosus and antiphospholipid syndrome--a video presentation.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Humans; Imm | 2015 |
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antige | 2016 |
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study.
Topics: Adult; Aspirin; Cardiovascular Diseases; Cause of Death; Female; Humans; Incidence; Italy; Kaplan-Me | 2016 |
Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Databases, Factual; Female; Heparin, Low- | 2017 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents | 2008 |
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antirheuma | 2009 |
Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Progression; Female; Hearing Loss; | 2009 |
Case records of the Massachusetts General Hospital. Case 5-2009. A 47-year-old woman with a rash and numbness and pain in the legs.
Topics: Antibodies, Antinuclear; Antirheumatic Agents; Aspirin; Biopsy; Diagnosis, Differential; Dry Eye Syn | 2009 |
Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.
Topics: Aspirin; Azetidines; Clinical Trials as Topic; Coronary Artery Disease; Drug Therapy, Combination; E | 2009 |
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
Topics: Algorithms; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female | 2009 |
Influenza virus B-associated hemophagocytic syndrome and recurrent pericarditis in a patient with systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Aspirin; Colchicine; Drug Therapy, Combination; Humans; Influenza B virus; | 2010 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatolo | 2010 |
OCT follow-up of systemic lupus erythematosus choroidopathy.
Topics: 4-Hydroxycoumarins; Adolescent; Adrenal Cortex Hormones; Angiography; Antibodies, Antinuclear; Aspir | 2010 |
[Sporadic hemiplegic migraine-like headache in a patient with systemic lupus erythematosus].
Topics: 1-Naphthylamine; Adult; Aspirin; Calcium Channel Blockers; Diagnosis, Differential; Female; Hemipleg | 2010 |
[Narcolepsy associated with systemic lupus erythematosus].
Topics: Adult; Aspirin; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lup | 2011 |
Systemic lupus erythematosus in a 3-month old male presenting as thrombocytopenia.
Topics: Aspirin; Fibrinolytic Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Lupus Eryth | 2011 |
Livedo racemosa, secondary to drug-induced systemic lupus erythematosus.
Topics: Adult; Aspirin; Autoantibodies; Histones; Humans; Livedo Reticularis; Lupus Erythematosus, Systemic; | 2010 |
Chorea as an unusual presenting feature of anti-phospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Chorea; Diagnosis, Differential; Humans; Lupus Erythematosus, Sy | 2010 |
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy.
Topics: Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Eptifibatide; Female; Fibrinolytic Agents; Heparin | 2011 |
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Topics: Abortion, Spontaneous; Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Biomarkers; C | 2011 |
Aspirin resistance may be associated with adverse pregnancy outcomes.
Topics: Adult; Aspirin; Cesarean Section; Drug Resistance; Female; Fetal Distress; Humans; Infant, Newborn; | 2011 |
[Successful completed pregnancies in patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Azathioprine; Birth Weight; Female; Follow-Up Studies; Gest | 2012 |
A fulminant neurologic presentation of systemic lupus erythematosus.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Brain; Cyclophosphamide; Diagnosis, Differential; | 2012 |
Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Eruptions; Drug Therapy, Combination; Enoxaparin; Female; F | 2012 |
[Mondor's thrombophlebitis and antiphospholipid antibodies].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndr | 2003 |
Anti-inflammatory agents in the treatment of connective tissue diseases.
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Aspirin; Chloroquine; Humans; Lupus Eryth | 1963 |
[Therapeutic results of aspirin corticosteroid combinations in rheumatic disease patients].
Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Aspirin; Fibromyalgia; Humans; Lupus Eryt | 1962 |
SYSTEMIC LUPUS ERYTHEMATOSUS WITH ERYTHERMALGIA.
Topics: Aspirin; Erythromelalgia; Humans; Lupus Erythematosus, Systemic; Temperature | 1963 |
DIAGNOSIS: DISCOID LUPUS ERYTHEMATOSUS?
Topics: Adrenal Cortex Hormones; Aspirin; Face; Hand; Hepatitis; Humans; Joint Diseases; Knee; Lupus Erythem | 1964 |
CUTANEOUS MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Adrenal Cortex Hormones; Alopecia; Anti-Bacterial Agents; Antimalarials; Aspirin; Blister; Drug Erup | 1964 |
[OUR PRESENT EXPERIENCE IN DIAGNOSIS AND TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS].
Topics: Adolescent; Adrenocorticotropic Hormone; Aspirin; Chloroquine; Cortisone; Diagnosis; Drug Therapy; H | 1964 |
ISOLATION AND CHARACTERIZATION OF MYCOPLASMAS (PPLO) FROM PATIENTS WITH RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS AND REITER'S SYNDROME.
Topics: Adolescent; Arthritis; Arthritis, Juvenile; Arthritis, Reactive; Arthritis, Rheumatoid; Aspirin; Com | 1965 |
[Which abortion prevention should be chosen in the case of antiphospholipid syndrome?].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; As | 2004 |
Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome | 2004 |
Therapeutic management of antiphospholipid syndrome in aspirin sensitive patients.
Topics: Antiphospholipid Syndrome; Aspirin; Humans; Lupus Erythematosus, Systemic; Platelet Aggregation Inhi | 2004 |
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Aspirin; Autoant | 2005 |
Splenic infarction in a pregnant woman with systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Aspirin; Cesarean Section; Drug Therap | 2005 |
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; | 2005 |
Minor physical anomalies are not increased in the offspring of mothers with systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Congenital Abnormalities; Fe | 2006 |
Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation Disorders; Clopidogrel; Coronary Artery D | 2006 |
Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
Topics: Adult; Antibodies, Antiphospholipid; Antibody Specificity; Anticoagulants; Antiphospholipid Syndrome | 2007 |
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Disease Progression; Female; | 2008 |
Successful full-term pregnancies with assisted reproduction supported with prednisolone, acetylsalicylic acid and high progesterone doses in a lupus patient.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Inflammatory Agents; Aspirin; Female | 2007 |
Fever associated with juvenile rheumatoid arthritis.
Topics: Adolescent; Adult; Arthritis, Juvenile; Aspirin; Child; Diagnosis, Differential; Female; Fever; Huma | 1967 |
Medical management of patients with disability due to arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Antimalarials; Arthritis, I | 1967 |
Fetal survival after prednisone suppression of maternal lupus-anticoagulant.
Topics: Adult; Antibodies, Antinuclear; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Fem | 1983 |
Hyporeninemic hypoaldosteronism in two patients with systemic lupus erythematosus.
Topics: 18-Hydroxycorticosterone; Adolescent; Aldosterone; Aspirin; Female; Fludrocortisone; Humans; Hyperka | 1984 |
Lupus anticoagulant in pregnancy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination; | 1984 |
Use of ibuprofen in unusual circumstances.
Topics: Arthritis, Rheumatoid; Aspirin; Bartter Syndrome; Cyclooxygenase Inhibitors; Digoxin; Drug Hypersens | 1984 |
[Use of the preparation essentiale in the therapy of lupus erythematosus].
Topics: Adolescent; Adult; Aged; Aspirin; Chloroquine; Chronic Disease; Drug Combinations; Drug Evaluation; | 1983 |
Effect of acetylsalicylic acid on renal function in systemic lupus erythematosus.
Topics: Adult; Aged; Aspirin; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Functio | 1982 |
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; | 1982 |
Management plan of systemic lupus erythematosus -- a flow chart.
Topics: Aspirin; Cyclophosphamide; Humans; Hydrocortisone; Lupus Erythematosus, Systemic; Prednisolone | 1980 |
Hepatic involvement in systemic lupus erythematosus. A case report.
Topics: Adult; Alkaline Phosphatase; Aspirin; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; | 1981 |
Pulmonary function abnormalities in systemic lupus erythematosus responsive to glucocorticoid therapy.
Topics: Adult; Aspirin; Dyspnea; Glucocorticoids; Humans; Lung; Lupus Erythematosus, Systemic; Male; Pleural | 1981 |
Treatment decisions in systemic lupus erythematosus.
Topics: Arthritis; Aspirin; Central Nervous System Diseases; Decision Making; Humans; Immunosuppressive Agen | 1980 |
The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.
Topics: Adolescent; Adult; Aged; Aspirin; Biopsy; Chemical and Drug Induced Liver Injury; Child, Preschool; | 1980 |
Effects of aspirin and acetaminophen on the liver.
Topics: Acetaminophen; Adolescent; Adult; Alcoholism; Arthritis, Juvenile; Aspirin; Child; Female; Humans; L | 1981 |
A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Lupus Erythemato | 1995 |
The management of thrombosis in the antiphospholipid-antibody syndrome.
Topics: Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; Hu | 1995 |
The management of thrombosis in the antiphospholipid-antibody syndrome.
Topics: Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; Hu | 1995 |
The management of thrombosis in the antiphospholipid-antibody syndrome.
Topics: Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; Hu | 1995 |
The management of thrombosis in the antiphospholipid-antibody syndrome.
Topics: Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; Hu | 1995 |
The significance of experimental models of systemic lupus erythematosus and antiphospholipid syndrome induced by idiotypic manipulation.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antiphosp | 1994 |
Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; | 1993 |
Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug | 1993 |
Anticardiolipin syndrome, aspirin therapy and fetal malformation.
Topics: Abnormalities, Drug-Induced; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; | 1993 |
Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Cells, Cultured; Female; Humans; Interleukin-3; Leukocytes, Mono | 1996 |
Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies.
Topics: Adrenal Cortex Hormones; Aging; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
Topics: Administration, Oral; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulan | 2000 |
Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coronary Disease; Humans; Hypertension; Lupus Eryt | 2000 |
Systemic lupus erythematosus associated with moyamoya syndrome.
Topics: Adolescent; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Stenos | 2000 |
Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis.
Topics: Adult; Aged; Annexin A5; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Aspirin; Blood Platelets; | 2001 |
Multiple sterile abscesses in antiphospholipid antibody syndrome.
Topics: Abscess; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Extremities; Female; | 2001 |
[Course of pregnancy in a patient with systemic lupus erythematosus--case report].
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Prednisone | 2002 |
Aspirin and renal function.
Topics: Arthritis, Rheumatoid; Aspirin; Humans; Kidney; Kidney Papillary Necrosis; Lupus Erythematosus, Syst | 1977 |
Renal prostaglandins in systemic lupus erythematosus.
Topics: Aspirin; Cyclooxygenase Inhibitors; Glomerular Filtration Rate; Humans; Kidney; Lupus Erythematosus, | 1978 |
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.
Topics: Adult; Antibodies, Antinuclear; Aspirin; Chloroquine; Complement C3; DNA; DNA Helicases; Female; Glo | 1979 |
Aspirin hepatotoxicity.
Topics: Adolescent; Adult; Aging; Aspirin; Chemical and Drug Induced Liver Injury; Child; Female; Humans; Li | 1978 |
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis.
Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents; Aspirin; Asthma; Cyclooxygenase Inhib | 1977 |
A circulating anticoagulant directed against factor XIa in systemic lupus erythematosus.
Topics: Adult; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Factor XI; Female; Hemorrhage; | 1979 |
[New aspects of drug induced lupus erythematosus (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Aged; Allopurinol; Aspirin; Humans; Lupus Erythematosus, Systemic; M | 1978 |
Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus.
Topics: Adult; Aspirin; Blood Urea Nitrogen; Creatinine; Female; Humans; Inulin; Kidney; Lupus Erythematosus | 1978 |
Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence?
Topics: Aspirin; Chemical and Drug Induced Liver Injury; Humans; Liver Function Tests; Lupus Erythematosus, | 1978 |
Aspirin-induced depression of renal function.
Topics: Adult; Arthritis; Arthritis, Rheumatoid; Aspirin; Blood Urea Nitrogen; Complement C3; Creatinine; Do | 1977 |
[Presocyl in the treatment of lupus erythematosus].
Topics: Adolescent; Adult; Aspirin; Chloroquine; Drug Combinations; Female; Humans; Lupus Erythematosus, Dis | 1976 |
Cerebral disorders of vision in systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Brain Diseases; Cerebrospinal Fluid; Electroencephalography | 1975 |
Aspirin hepatitis.
Topics: Adolescent; Anemia, Sickle Cell; Arthritis, Juvenile; Aspartate Aminotransferases; Aspirin; Chemical | 1975 |
Intravascular coagulation in acute lupus erythematosus.
Topics: Acute Disease; Adult; Aspirin; Disseminated Intravascular Coagulation; Female; Headache; Hemolysis; | 1975 |
Antiphospholipid antibodies in pregnancy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Female; Humans; Lupus Coagulation Inhibito | 1992 |
[Severe hepatitis with encephalopathy induced by acetylsalicylic acid in a case of lupus erythematosus disseminatus].
Topics: Aspirin; Chemical and Drug Induced Liver Injury; Female; Hepatic Encephalopathy; Humans; Lupus Eryth | 1992 |
Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.
Topics: Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Cardiolipins; DNA; Female; Humans; Lupus Coag | 1992 |
Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies.
Topics: Adrenal Cortex Hormones; Adult; Antiphospholipid Syndrome; Aspirin; Cardiolipins; Drug Therapy, Comb | 1992 |
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Topics: Aged; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hepa | 1992 |
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Topics: Aged; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hepa | 1992 |
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Topics: Aged; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hepa | 1992 |
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
Topics: Aged; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hepa | 1992 |
Cerebral ischemia associated with anticardiolipin antibodies.
Topics: Adult; Aged; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Brain Ischemia; Cardiolipins; Cereb | 1992 |
Osteonecrosis of femoral head in SLE patient after short period of corticosteroid therapy--a case report.
Topics: Adolescent; Aspirin; Drug Combinations; Female; Femur Head Necrosis; Humans; Lupus Erythematosus, Sy | 1991 |
[Aspirin and pregnancy].
Topics: Aspirin; Blood Coagulation Factors; Female; Fetal Death; Fetal Growth Retardation; Humans; Hypertens | 1990 |
[Clinical study and therapy of systemic lupus erythematosus and pregnancy].
Topics: Antibodies, Antinuclear; Aspirin; Female; Heparin; Humans; Infant, Newborn; Kidney Function Tests; L | 1990 |
Fetal loss treatment in patients with antiphospholipid antibodies.
Topics: Abortion, Habitual; Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Humans; Lupus Coagul | 1989 |
Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.
Topics: Abortion, Spontaneous; Antibodies; Aspirin; Female; Fetal Death; Humans; Lupus Erythematosus, System | 1989 |
Fetal demise associated with lupus anticoagulant: clinical features and results of treatment.
Topics: Adult; Aspirin; Autoantibodies; Blood Coagulation; Dipyridamole; Female; Heparin; Humans; Immunosupp | 1989 |
Low-dose aspirin in pregnancy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Lupus Erythematosu | 1988 |
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
Topics: Aspirin; Autoantibodies; Female; Fetal Death; Humans; Lupus Erythematosus, Systemic; Phospholipids; | 1989 |
[Aspirin in the treatment of inflammatory rheumatism in 1987].
Topics: Adult; Arthritis, Rheumatoid; Aspirin; Child; Humans; Inflammation; Lupus Erythematosus, Systemic; R | 1987 |
Rheumatoid arthritis: diagnosis and management.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Arthritis, Infectious; Arthritis, Juvenile; Arthritis, | 1986 |
Patterns of in vitro aspirin hydrolysis rates in rheumatoid arthritis and systemic lupus erythematosus.
Topics: Arthritis, Rheumatoid; Aspirin; Erythrocytes; Hematocrit; Humans; Hydrolysis; Lupus Erythematosus, S | 1986 |
Acute granulocytic leukemia following systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aspirin; Cyclophosphamide; Cytarabine; Humans; Immunosuppressi | 1985 |
Reye syndrome associated with aspirin therapy for systemic lupus erythematosus.
Topics: Adolescent; Ammonia; Aspartate Aminotransferases; Aspirin; Biopsy, Needle; Electroencephalography; F | 1985 |
Anti-inflammatory therapy during pregnancy and lactation.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Female; Humans; I | 1985 |
Systemic lupus erythematosus in the elderly.
Topics: Aged; Arthritis, Rheumatoid; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Ag | 1972 |
Letter: Serum-transaminase levels and salicylates.
Topics: Adult; Alkaline Phosphatase; Aspirin; Female; Humans; Liver; Lupus Erythematosus, Systemic; Middle A | 1974 |
The problem of drug hypersensitivity.
Topics: Antibody Formation; Aspirin; Cell Migration Inhibition; Drug Hypersensitivity; Haptens; Hemagglutina | 1971 |
Anti-inflammatory drugs in rheumatic diseases.
Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Aspirin | 1974 |
The early natural history of juvenile rheumatoid arthritis. A 10-year follow-up study of 100 cases.
Topics: Adolescent; Antimalarials; Arthritis, Juvenile; Aspirin; Child; Child, Preschool; Diagnosis, Differe | 1968 |
Lung disease caused by drugs.
Topics: Aspirin; Asthma; Contraceptives, Oral; Drug-Related Side Effects and Adverse Reactions; Eosinophilia | 1969 |
Which drugs for which rheumatic disorder?
Topics: Analgesics; Arthritis, Rheumatoid; Aspirin; Gold; Gout; Humans; Indomethacin; Lupus Erythematosus, S | 1972 |
Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Aspirin; Biopsy; Chemical and Drug Induced | 1974 |
Aspirin hepatitis.
Topics: Adult; Aspirin; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Liver Function Tests; | 1974 |
Esophageal motility in systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Aspirin; Azathioprine; Chloroquine; Deglutition Disorders; Dilatation; Drug | 1974 |
Letter: Aspirin hepatotoxicity.
Topics: Adolescent; Aspirin; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Lupus Erythemato | 1974 |
Letter: Aspirin hepatotoxicity.
Topics: Aspirin; Chemical and Drug Induced Liver Injury; Humans; Liver; Liver Diseases; Liver Function Tests | 1974 |
General considerations in the treatment of systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Allergens; Antimalarials; Aspirin; Contraception; Contraceptives, Oral; Fem | 1969 |